Monday, January 25, 2021
wellness India Expo
Home Tags Serum Institute

Tag: Serum Institute

Wait over as DCGI approves Bharat Biotech & Serum Institute COVID-19...

After adequate examination, Central Drugs Standard Control Organisation decided to accept the recommendations of the Expert Committee, and accordingly, vaccines of Serum and Bharat Biotech are being approved for restricted use in an emergency situation

Stakeholder orchestration a key for effective vaccination program: experts at NASSCOM

The funding for such large-scale distribution would be huge, and India should be ready with a funding of around Rs 80,000 crore for the next one year for distribution of the COVID-19 vaccine......................

India in the forefront of developing COVID-19 vaccines: Dr Harsh Vardhan

Dr Harsh Vardhan at the India-Portugal Technology Summit2020 “The next iteration of this collaboration will be to encourage new solutions based on cutting edge technologies such as Machine Learning and Artificial Intelligence”...................

PM Modi visits India’s top private vaccine manufacturing facilities

On 28th November, Prime Minister of India, Narendra Modi undertook a three-city tour to the Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad, and Serum Institute of India in Pune......................

ICMR backed Serum Institute’s COVISHIELD completes enrolment of Phase III clinical...

Under the strategic alliance, Indian Council for Medical Research is providing continuous support to Serum Institute of India in conducting and funding the ongoing clinical trials of COVISHIELD across 15 centres in India....................

IAVI, Merck & Serum Institute join forces to develop monoclonal antibodies...

Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response. The approach is complementary to future COVID-19 vaccines.........................

Serum Institute to produce additional 100 million COVID-19 vaccine doses with...

The collaboration between the Serum Institute of India, Gavi, the Vaccine Alliance and the Bill & Melinda Gates Foundation will accelerate manufacturing and delivery of up to an additional 100 million doses of future safe and effective COVID-19 vaccines, priced at a maximum of US$ 3 per dose, for low- and middle-income countries in 2021..................

DCGI nod to Serum Institute for conducting human trials of Oxford...

The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................

COVID-19: Supported by DBT, Serum Institute’s rBCG vaccine efficacy trial enrolls...

Serum Institute of India has been supported under the Department of Biotechnology’s National Biopharma Mission for conduct of a multisite randomized double-blinded placebo-controlled phase III clinical trial of a recombinant BCG vaccine candidate, VPM1002.............................

DCGI approves India’s first indigenous pneumonia vaccine by Serum Institute

On 14th July, 2020, Serum Institute of India, Pune has been granted permission to manufacture domestically developed first Pneumococcal Polysaccharide Conjugate Vaccine